STOCK TITAN

Burning Rock Biotech (BNR) Debt by Year

BNR NASDAQ

Burning Rock Biotech Limited carried $243K in long-term debt against $68.4M in cash and equivalents at the end of fiscal year 2025. The change in long-term debt from the prior fiscal year is not meaningful, because that figure was zero or negative. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters Burning Rock Biotech Limited has filed alongside them.

FY2025 annual
Long-Term Debt $243K
Cash & Equivalents $68.4M
YoY (CNY) n/m
Source SEC Filings (20-F/6-K) Latest period FY2025, ended Dec 31, 2025 Reported Currency USD, translated from CNY

Amounts are shown in US dollars, translated from CNY at the rate recorded for each period. Growth rates marked (CNY) are measured in CNY, the currency the company reports in, so a move in the exchange rate does not count as growth.

Annual figures, oldest first. Point at a bar to read its period.

BNR Debt & Cash by Fiscal Year

Figures are in USD, translated from CNY at the rate recorded for each period. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2520-FFY2420-FFY2320-FFY2220-FFY2120-FFY2020-FFY1920-FFY1820-F
Long-Term Debt$243Kn/m$0N/AN/AN/A$0-100.0%$2.6MN/A
Cash & Equivalents$68.4M-8.0%$71.2M-15.5%$86.6M-32.1%$131.3M-36.7%$224.6M-24.5%$290.5M+1911.3%$13.5M+1.0%$13.6M

BNR Debt & Cash by Quarter

Figures are in USD, translated from CNY at the rate recorded for each period. Each change compares the quarter with the same quarter a year earlier.

MetricQ4'2520-FQ4'2420-FQ4'2320-FQ4'2220-FQ2'226-KQ4'2120-FQ4'2020-FQ4'1920-F
Long-Term Debt$243Kn/m$0N/AN/AN/AN/A$0-100.0%$2.6M
Cash & Equivalents$68.4M-8.0%$71.2M-15.5%$86.6M-32.1%$131.3M-36.7%$171.5M$224.6M-24.5%$290.5M+1911.3%$13.5M

What long-term debt means

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.

More Burning Rock Biotech Limited financials

Frequently Asked Questions

Burning Rock Biotech Limited carried $243K in long-term debt against $68.4M in cash and equivalents at the end of fiscal year 2025.

Burning Rock Biotech Limited (BNR) reported $0 in long-term debt in fiscal year 2024 and $243K in long-term debt in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.

Burning Rock Biotech Limited (BNR) reported $243K in long-term debt in Q4 2025. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Burning Rock Biotech Limited (BNR) reported on that line in every period on record.